loadpatents
name:-0.032799959182739
name:-0.019908905029297
name:-0.0099389553070068
Korver; Wouter Patent Filings

Korver; Wouter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Korver; Wouter.The latest application filed is for "anti-siglec-7 antibodies having reduced effector function".

Company Profile
9.23.31
  • Korver; Wouter - South San Francisco CA
  • Korver; Wouter - Mountain View CA
  • Korver; Wouter - San Carlos CA
  • Korver; Wouter - San Francisco CA
  • Korver; Wouter - Menlo Park CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-CD38 antibodies
Grant 11,434,304 - Elias , et al. September 6, 2
2022-09-06
Anti-CD38 binding domains
Grant 11,414,496 - Elias , et al. August 16, 2
2022-08-16
Fusions of antibodies to CD38 and attenuated interferon alpha
Grant 10,981,986 - Wilson, Jr. , et al. April 20, 2
2021-04-20
Anti-siglec-7 Antibodies Having Reduced Effector Function
App 20210054072 - Bebbington; Christopher ;   et al.
2021-02-25
Anti-cd38 Binding Domains
App 20200231696 - Elias; Kathleen Ann ;   et al.
2020-07-23
Anti-cd38 Antibodies
App 20200040105 - Elias; Kathleen Ann ;   et al.
2020-02-06
Conjugated Anti-cd38 Antibodies
App 20200031951 - Elias; Kathleen Ann ;   et al.
2020-01-30
Anti-CD38 antibodies
Grant 10,494,444 - Elias , et al. De
2019-12-03
Conjugated anti-CD38 antibodies
Grant 10,336,833 - Elias , et al.
2019-07-02
Anti-siglec-7 Antibodies For The Treatment Of Cancer
App 20190194323 - Bebbington; Christopher ;   et al.
2019-06-27
Anti-cd38 Antibodies
App 20180066069 - Elias; Kathleen Ann ;   et al.
2018-03-08
Conjugated Anti-cd38 Antibodies
App 20180016349 - ELIAS; Kathleen Ann ;   et al.
2018-01-18
Antibodies To Ntb-a
App 20170334989 - Abo; Arie ;   et al.
2017-11-23
Methods And Compositions For Systemic Lupus Erythematosus
App 20170299590 - HAWTIN; Rachael ;   et al.
2017-10-19
Anti-CD38 antibodies
Grant 9,790,285 - Elias , et al. October 17, 2
2017-10-17
Fusions Of Antibodies To Cd38 And Attenuated Interferon Alpha
App 20170233449 - Wilson, Jr.; David S. ;   et al.
2017-08-17
Conjugated anti-CD38 antibodies
Grant 9,676,869 - Elias , et al. June 13, 2
2017-06-13
Fusions of antibodies to CD38 and attenuated interferon alpha
Grant 9,611,322 - Wilson, Jr. , et al. April 4, 2
2017-04-04
Polypeptide Constructs And Uses Thereof
App 20160367695 - Wilson; David S. ;   et al.
2016-12-22
Methods And Compositions For Systemic Lupus Erythematosus
App 20160245794 - Hawtin; Rachael ;   et al.
2016-08-25
Antibodies To Ntb-a
App 20150376273 - Abo; Arie ;   et al.
2015-12-31
Conjugated Anti-cd38 Antibodies
App 20150291702 - ELIAS; Kathleen Ann ;   et al.
2015-10-15
Conjugated anti-CD38 antibodies
Grant 9,102,744 - Elias , et al. August 11, 2
2015-08-11
Anti-cd38 Antibodies
App 20150203587 - Elias; Katheen Ann ;   et al.
2015-07-23
Antibodies to NTB-A
Grant 8,993,726 - Abo , et al. March 31, 2
2015-03-31
Anti-CD38 antibodies
Grant 8,926,969 - Elias , et al. January 6, 2
2015-01-06
Polypeptide Constructs And Uses Thereof
App 20140248238 - Wilson, JR.; David S. ;   et al.
2014-09-04
Conjugated Anti-cd38 Antibodies
App 20140155584 - Elias; Kathleen Ann ;   et al.
2014-06-05
Reducing The Risk Of Human Anti-human Antibodies Through V Gene Manipulation
App 20130344514 - Kellermann; Sirid-Aimee ;   et al.
2013-12-26
Methods of monitoring a human anti-human antibody response and inhibitors thereof
Grant 8,597,615 - Kellermann , et al. December 3, 2
2013-12-03
Antibodies To Ntb-a
App 20130273077 - Abo; Arie ;   et al.
2013-10-17
Antibodies to CLL-1
Grant 8,536,310 - Abo , et al. September 17, 2
2013-09-17
Anti-cd38 Antibodies
App 20130171154 - Elias; Kathleen Ann ;   et al.
2013-07-04
Anti-CD38 antibodies
Grant 8,362,211 - Elias , et al. January 29, 2
2013-01-29
Reducing The Risk Of Human Anti-human Antibodies Through V Gene Manipulation
App 20120219976 - KELLERMANN; SIRID-AIMEE ;   et al.
2012-08-30
Anti-cd38 Antibodies
App 20120201827 - Elias; Kathleen Ann ;   et al.
2012-08-09
Reducing the risk of human anti-human antibodies through V gene manipulation
Grant 8,198,508 - Kellermann , et al. June 12, 2
2012-06-12
Antibodies to NTB-A
Grant 8,193,320 - Abo , et al. June 5, 2
2012-06-05
Antibodies To Ntb-a
App 20110171204 - Abo; Arie ;   et al.
2011-07-14
Antibodies to NTB-A
Grant 7,847,067 - Abo , et al. December 7, 2
2010-12-07
Antibodies To Irem-1
App 20100291108 - Abo; Arie ;   et al.
2010-11-18
Antibodies To Cll-1
App 20100285037 - Abo; Arie ;   et al.
2010-11-11
Reducing The Risk Of Human Anti-human Antibodies Through V Gene Manipulation
App 20100028906 - Kellermann; Sirid-Aimee ;   et al.
2010-02-04
Determining the risk of human anti-human antibodies in transgenic mice
Grant 7,625,549 - Kellermann , et al. December 1, 2
2009-12-01
Antibodies To Ntb-a
App 20090181009 - Abo; Arie ;   et al.
2009-07-16
Reducing the risk of human anti-human antibodies through V gene manipulation
App 20060021074 - Kellermann; Sirid Aimee ;   et al.
2006-01-26
Reducing the risk of human anti-human antibodies through V gene manipulation
App 20050260679 - Kellerman, Sirid-Aimee ;   et al.
2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed